Castro-Dopico et al., 2019 - Google Patents
IgG and Fcγ receptors in intestinal immunity and inflammationCastro-Dopico et al., 2019
View HTML- Document ID
- 4809115581743107598
- Author
- Castro-Dopico T
- Clatworthy M
- Publication year
- Publication venue
- Frontiers in immunology
External Links
Snippet
Fcγ receptors (FcγR) are cell surface glycoproteins that mediate cellular effector functions of immunoglobulin G (IgG) antibodies. Genetic variation in FcγR genes can influence susceptibility to a variety of antibody-mediated autoimmune and inflammatory disorders …
- 108010073807 IgG Receptors 0 title abstract description 87
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Castro-Dopico et al. | IgG and Fcγ receptors in intestinal immunity and inflammation | |
Reber et al. | Potential effector and immunoregulatory functions of mast cells in mucosal immunity | |
van Gool et al. | IgA and FcαRI: Versatile players in homeostasis, infection, and autoimmunity | |
Espéli et al. | Fcγ RIIB and autoimmunity | |
Actor | Elsevier's Integrated Review Immunology and Microbiology E-Book: with STUDENT CONSULT Online Access | |
Sinkora et al. | Progress in the use of swine in developmental immunology of B and T lymphocytes | |
Kubo et al. | Introduction to mechanisms of allergic diseases | |
Fleming et al. | B cell class switching in intestinal immunity in health and disease | |
US20100143370A1 (en) | Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease | |
Wang et al. | Function and dysfunction of plasma cells in intestine | |
WO2015036004A1 (en) | Method for preparing an improved atg composition | |
Weitkamp et al. | Immunology of the Fetus and Newborn | |
Ahmed et al. | The major players in adaptive immunity: 1. Humoral immunity | |
Keogan et al. | Concise clinical immunology for healthcare professionals | |
Mattos et al. | The immunology of B-1 cells: from development to aging | |
Cominelli et al. | The mucosal immune system and gastrointestinal inflammation | |
Das | The regulatory effects of circulating normal immunoglobulins on autophagy and Th17 response | |
Neu | Modeling Multiple Sclerosis Medication in Mice: Regulatory B Cells Escape Long-Term αCD20 B Cell-Depletion, Preserving Health in the Face of Autoimmunity | |
Zhou | Secretory IgA Enhances Gut B Cells Priming and Systemic IgG Responses Towards Commensals | |
Castro Dopico | Investigating the role of IgG and Fcγ receptors in intestinal inflammation | |
Wang | Uncovering the Roles of B Lymphocytes in the NOD Mouse Model of Type 1 Diabetes Through Genetic Engineering and Therapeutic Targeting | |
Richoz | Investigating the role of kidney mononuclear phagocytes in immune complex-induced inflammation. | |
Dotsenko et al. | Clinical immunology and allergology | |
Deramoudt | B cells and humoral immunity in demyelinating diseases of the central nervous system | |
Dawod | THE ROLE OF TOLL-LIKE RECEPTOR 2 IN MODULATION OF BREAST MILK COMPONENTS AND ORAL TOLERANCE |